Life Sciences Strategy and implementing the Accelerated Access Review

Priorities for the Government’s Life Sciences Strategy, implementation of the Accelerated Access Review, and broader issues of access to diagnostics, treatments and technologies.

The Life Sciences Strategy and implementing the recommendations of the Accelerated Access Review
Authored and supported by: Action Duchenne, Breast Cancer Now, Cancer52, Cystic Fibrosis Trust, Diabetes UK, Digital Health & Care Alliance, Genetic Alliance UK, Kidney Research UK, National Voices, Parkinson’s UK, Prostate Cancer UK, and the Tuberous Sclerosis Association.
April, 2017